Načítá se...

Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)

Monoamine neurotransmitter deficiency has been implicated in the etiology of neuropsychiatric symptoms associated with chronic hyperphenylalaninemia in phenylketonuria (PKU). Two proposed explanations for neurotransmitter deficiency in PKU include first, that chronically elevated blood L-phenylalani...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harding, Cary O., Winn, Shelley R., Gibson, K. Michael, Arning, Erland, Bottiglieri, Teodoro, Grompe, Markus
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119869/
https://ncbi.nlm.nih.gov/pubmed/24487571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10545-013-9675-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!